The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
Part A is amended as follows:
the entry for Deltamethrin is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Deltamethrin | AT’ |
the entry for Diflufenican is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Diflufenican | CZ’ |
the entry for Fluoxastrobin is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Fluoxastrobin | DE’ |
the entry for Prothioconazole is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Prothioconazole | PL’ |
Part B is amended as follows:
the entry for Epoxiconazole is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Epoxiconazole | PL’ |
the entry for Tebuconazole is replaced by the following:
Active substance | Rapporteur Member State | Co-rapporteur Member State
‘Tebuconazole | DK’ |